Cidara hits target enrollment for Phase 3 flu trial ahead of peak season
CD388 is administered as a single 450-milligram subcutaneous dose in adults and adolescents
CD388 is administered as a single 450-milligram subcutaneous dose in adults and adolescents
The trial tested six injectable doses and three oral doses over as long as 36 weeks
Solventum aims to accelerate innovation in acute wound care, expand its market reach, and deliver enhanced solutions for patients, clinicians, and shareholders
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
The European Commission’s green light marks Breyanzi’s fourth indication in Europe and extends access to patients across all EU and EEA countries
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
The Eurasian Patent Organization (EAPO) has granted Patent, protecting the company’s sublingual delivery technology for anticancer drugs used to treat autoimmune and neurodegenerative diseases
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
Subscribe To Our Newsletter & Stay Updated